A machine learning approach identifies distinct early-symptom cluster phenotypes which correlate with hospitalization, failure to return to activities, and prolonged COVID-19 symptoms
Nusrat J Epsi, John H. Powers, David A Lindholm, Katrin Mende, Allison M. W. Malloy, Anuradha Ganesan, Nikhil Huprikar, Tahaniyat Lalani, Alfred G. Smith, Rupal Mody, Milissa U. Jones, Samantha Bazan, Rhonda E Colombo, Christopher Colombo, Evan Ewers, Derek Larson, Catherine M Berjohn, Carlos J Maldonado, Paul W. Blair, Josh Chenoweth, David Saunders, Jeffrey Livezey, Ryan C. Maves, Margaret Edwards, Julia S Rozman, Mark P. Simons, David R. Tribble, Brian K. Agan, Timothy Burgess, Simon Pollett, Stephanie A. Richard, for the EPICC COVID-19 Cohort Study Group
Abstract
BACKGROUND: Accurate COVID-19 prognosis is a critical aspect of acute and long-term clinical management. We identified discrete clusters of early stage-symptoms which may delineate groups with distinct disease severity phenotypes, including risk of developing long-term symptoms and associated inflammatory profiles. METHODS: 1,273 SARS-CoV-2 positive U.S. Military Health System beneficiaries with quantitative symptom scores (FLU-PRO Plus) were included in this analysis. We employed machine-learning approaches to identify symptom clusters and compared risk of hospitalization, long-term symptoms, as well as peak CRP and IL-6 concentrations. RESULTS: We identified three distinct clusters of participants based on their FLU-PRO Plus symptoms: cluster 1 ("Nasal cluster") is highly correlated with reporting runny/stuffy nose and sneezing, cluster 2 ("Sensory cluster") is highly correlated with loss of smell or taste, and cluster 3 ("Respiratory/Systemic cluster") is highly correlated with the respiratory (cough, trouble breathing, among others) and systemic (body aches, chills, among others) domain symptoms. Participants in the Respiratory/Systemic cluster were twice as likely as those in the Nasal cluster to have been hospitalized, and 1.5 times as likely to report that they had not returned-to-activities, which remained significant after controlling for confounding covariates (P < 0.01). Respiratory/Systemic and Sensory clusters were more likely to have symptoms at six-months post-symptom-onset (P = 0.03). We observed higher peak CRP and IL-6 in the Respiratory/Systemic cluster (P < 0.01). CONCLUSIONS: We identified early symptom profiles potentially associated with hospitalization, return-to-activities, long-term symptoms, and inflammatory profiles. These findings may assist in patient prognosis, including prediction of long COVID risk.